Dear John,

Today, we are highlighting our May 29 Insider event on FDA changes under Trump’s second term but we also want to note our first ever Insider trend report is dropping next Tuesday.

Become an Insider today to join the event later this month and get the trend report (which is on AI in health care).

FDA’s First 100 Days Under the Second Trump Administration

The second Trump administration's restructuring of the federal branch of government has affected HHS, particularly the U.S. Food and Drug Administration (FDA).

In this 60-minute virtual event, moderator Rachel Sachs along with panelists Richard Hughes IV and Arti Rai will review the policy and administrative changes at the FDA during Trump’s first 100 days in office during his second administration. 

With a focus on vaccine policy and drug development and innovation, attendees will leave with a better understanding of what’s happened at the FDA and what may come in the near future. 

Health Affairs Branded Post:

UnitedHealthcare Community & State

Sponsored by UnitedHealthcare

A Health Podyssey: Caitlin Carroll on Hospital Closures Ultimately Causing Higher Prices

Health Affairs This Week: Trump's Deregulation Era & The Big Budget Reconciliation's Health Care Impact w/ Katie Keith

Community & State is the business segment of UnitedHealthcare that provides health care coverage for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health plans. These state-based health plans meet local needs, while leveraging the national resources of UnitedHealthcare.

How Can the New Age-Friendly Hospital Measure Transform the Inpatient Experience

The House Republican Budget Reconciliation Legislation: Unpacking The Coverage Provisions

Katie Keith

part of our Health Policy At A Crossroads series

Administration Releases Medicare Drug Price Negotiation Program Draft Guidance For 2028

Kristi Martin and Rachel Sachs

CMS Proposes To Limit Provider Taxes

Arielle Kane

part of our Medicaid Financing series

Third-Party Administrators – The Middlemen Of Self-Funded Health Insurance

Karen Handorf et al.

part of our Provider Prices In The Commercial Sector series

GLP-1 Coverage In State-Regulated Markets: A Turbulent Atmosphere With No Sign Of Calming

Katherine Hempstead

part of our Health Policy At A Crossroads series

In Price Negotiations, Medicare Should Reassess How It Determines A ‘Qualifying Single Source Drug’

T. Joseph Mattingly II

Health Insurance Transitions For Young People With Diabetes Can Be Life Threatening

Amy Killelea and Christine H. Monahan

Revisiting Consumer Health Agreements And Consent In The Post-23andMe Era

Adithi Iyer

Creating A Pathway To Scale Up Acute Hospital Care At Home

Tara Jain and Ronald Paulus

Predictive Analytics Play A Critical Role In Curbing Measles Outbreaks

Sarah Gillani et al.